What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.15%
Annual Rate
CNY 0.08Paid semi-annual
Payout Ratio
80.0%Moderate
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.07BCNY
906.42M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
993.80x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Revenue (TTM)
471.08MCNY
70.30M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
1.30%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Beta
0.8730x
vs all stocks
Updated Sep 21, 2026
52-Week Change
106.16%
vs all stocks
Updated Sep 21, 2026
Forward Annual Dividend Yield
0.15%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
6.07BCNY
906.42M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
5.49BCNY
819.90M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
993.80x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Forward P/E
60.48x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Price to Sales (TTM)
12.89x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Price to Book (MRQ)
3.21x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Enterprise to Revenue
11.66x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Enterprise to EBITDA
92.02x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 77.7×.Updated Sep 21, 2026
Gross Margin
21.31%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Profit Margin
1.30%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Operating Margin
-6.52%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Return on Assets (TTM)
-0.01%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Return on Equity (TTM)
0.11%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Revenue (TTM)
471.08MCNY
70.30M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
4.07CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
53.40%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Gross Profit (TTM)
98.22MCNY
14.66M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
70.72MCNY
10.55M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
6.14MCNY
916.27K · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
80.75%
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
17.86MCNY
2.67M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-175.79MCNY
-26.23M · vs all stocks (USD)
Updated Sep 21, 2026
Forward Annual Dividend Rate
0.0800CNYUpdated Sep 21, 2026
Forward Annual Dividend Yield
0.15%
vs all stocks
Updated Sep 21, 2026
Trailing Annual Dividend Rate
0.2900CNYUpdated Sep 21, 2026
Trailing Annual Dividend Yield
0.54%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
80.00%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 580%.Updated Sep 21, 2026
Minority Interest (Equity)
4.98MCNYFY2025 · Dec 31, 2025
Revenue
356.69MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
276.93MCNYFY2025 · Dec 31, 2025
Gross Profit
79.76MCNYFY2025 · Dec 31, 2025
Operating Income
3.22MCNY
480.14K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.34MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.22MCNYFY2025 · Dec 31, 2025
Net Income
2.55MCNYFY2025 · Dec 31, 2025
EBIT
1.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
70.72MCNYFY2025 · Dec 31, 2025
Research & Development
21.96MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.25MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.55MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
463.50KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.55MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.07MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-61.44MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-152.61MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
371.03MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.55MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.57MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-34.13MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-32.44MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-91.17MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.52BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.66BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
51.53MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-30.56MCNYFY2025 · Dec 31, 2025
Other Financing Charges
1.06MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-29.50MCNYFY2025 · Dec 31, 2025
Shares Outstanding
122.25MSharesUpdated Sep 21, 2026
Float Shares
54.01MSharesUpdated Sep 21, 2026
% Held by Insiders
67.78%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
5.46%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
760.93MCNY
113.55M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
6.22CNYUpdated Sep 21, 2026
Total Debt (MRQ)
168.36MCNY
25.12M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.0884x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Current Ratio (MRQ)
3.83x
vs Medical Instruments & Supplies peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
15.48CNYUpdated Sep 21, 2026
Total Assets
2.01BCNY
299.33M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.02BCNYFY2025 · Dec 31, 2025
Total Liabilities
161.97MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
989.76MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
42.62MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
119.35MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
371.03MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
435.11MCNYFY2025 · Dec 31, 2025
Accounts Receivable
90.26MCNYFY2025 · Dec 31, 2025
Inventory
100.67MCNYFY2025 · Dec 31, 2025
Accounts Payable
91.44MCNYFY2025 · Dec 31, 2025
Short-term Debt
3.50MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
84.33KCNYFY2025 · Dec 31, 2025
Long-term Debt
27.92MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
122.25MCNYFY2025 · Dec 31, 2025
Retained Earnings
452.19MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.84BCNY
275.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
23.00CNYUpdated Sep 21, 2026
52-Week High
53.88CNYUpdated Sep 21, 2026
52-Week Change
106.16%
vs all stocks
Updated Sep 21, 2026
Beta
0.8730x
vs all stocks
Updated Sep 21, 2026
50-Day MA
36.10CNYUpdated Sep 21, 2026
200-Day MA
31.34CNYUpdated Sep 21, 2026
Avg 10-Day Volume
5.17MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
5.21MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
0.0500CNYUpdated Sep 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 993.8×, higher than 95% of its Medical Instruments & Supplies peers (median 26.23×)Significant